1. Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma
   Lai Wei et al, 2022, Chinese Medicine CrossRef
2. ATP1A1 is a promising new target for melanoma treatment and can be inhibited by its physiological ligand bufalin to restore targeted therapy efficacy
   Laura Soumoy et al, 2024, Cancer Cell International CrossRef
3. An overview of the past decade of bufalin in the treatment of refractory and drug-resistant cancers: current status, challenges, and future perspectives
   Qingmei Ye et al, 2023, Frontiers in Pharmacology CrossRef
4. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
   Weixiao An et al, 2019, Frontiers in Pharmacology CrossRef